Fadrozole
Fadrozole
Fadrozole (pronounced: fah-droh-zohl) is a non-steroidal aromatase inhibitor used primarily in the treatment of breast cancer.
Etymology
The term "Fadrozole" is derived from the chemical name 4-(5,6,7,8-Tetrahydroimidazo[1,5-a]pyridin-5-yl)benzonitrile hydrochloride. The name is a combination of parts of the chemical name, although the exact origin is not clearly documented.
Usage
Fadrozole is used as a treatment for hormone-responsive breast cancer. It works by inhibiting the enzyme aromatase, which is responsible for the conversion of androgens to estrogens in the body. By inhibiting this enzyme, Fadrozole reduces the levels of estrogen in the body, which can slow or stop the growth of certain types of breast cancer cells that require estrogen to grow.
Related Terms
- Aromatase inhibitor: A class of drugs that inhibit the enzyme aromatase, which is responsible for the conversion of androgens to estrogens in the body.
- Breast cancer: A type of cancer that forms in the cells of the breasts.
- Estrogen: A group of hormones that play an important role in the normal sexual and reproductive development in women.
- Androgen: Any natural or synthetic compound, usually a steroid hormone, that stimulates or controls the development and maintenance of male characteristics.
See Also
External links
- Medical encyclopedia article on Fadrozole
- Wikipedia's article - Fadrozole
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski